These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 26269678)
1. Transcatheter arterial infusion for advanced hepatocellular carcinoma: Who are candidates? Suzuki E; Chiba T; Ooka Y; Ogasawara S; Tawada A; Motoyama T; Kanogawa N; Saito T; Yoshikawa M; Yokosuka O World J Gastroenterol; 2015 Aug; 21(29):8888-93. PubMed ID: 26269678 [TBL] [Abstract][Full Text] [Related]
2. Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with portal vein invasion: safety, efficacy, and prognostic factors. Chern MC; Chuang VP; Liang CT; Lin ZH; Kuo TM J Vasc Interv Radiol; 2014 Jan; 25(1):32-40. PubMed ID: 24290099 [TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma. Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662 [TBL] [Abstract][Full Text] [Related]
4. Treatment outcome of transcatheter arterial chemoinfusion according to anticancer agents and prognostic factors in patients with advanced hepatocellular carcinoma (TNM stage IVa). Ahn SH; Han KH; Park JY; Youn YH; Moon CM; Lee KS; Chon CY; Moon YM; Lee DY; Lee JT Yonsei Med J; 2004 Oct; 45(5):847-58. PubMed ID: 15515195 [TBL] [Abstract][Full Text] [Related]
5. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort. Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438 [TBL] [Abstract][Full Text] [Related]
6. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization. Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization. Hatooka M; Kawaoka T; Aikata H; Morio K; Kobayashi T; Hiramatsu A; Imamura M; Kawakami Y; Murakami E; Waki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Chayama K Anticancer Res; 2016 Jul; 36(7):3523-9. PubMed ID: 27354618 [TBL] [Abstract][Full Text] [Related]
8. Transcatheter arterial infusion chemotherapy with cisplatin-lipiodol suspension in patients with hepatocellular carcinoma. Ikeda M; Maeda S; Ashihara H; Nagahama H; Tanaka M; Sasaki Y J Gastroenterol; 2010; 45(1):60-7. PubMed ID: 19655081 [TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma. Li JH; Xie XY; Zhang L; Le F; Ge NL; Li LX; Gan YH; Chen Y; Zhang JB; Xue TC; Chen RX; Xia JL; Zhang BH; Ye SL; Wang YH; Ren ZG World J Gastroenterol; 2015 Apr; 21(13):3970-7. PubMed ID: 25852283 [TBL] [Abstract][Full Text] [Related]
10. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence. Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786 [TBL] [Abstract][Full Text] [Related]
11. Transcatheter arterial infusion chemotherapy with a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma refractory to transcatheter arterial chemoembolization. Iwasa S; Ikeda M; Okusaka T; Ueno H; Morizane C; Nakachi K; Mitsunaga S; Kondo S; Hagihara A; Shimizu S; Satake M; Arai Y Jpn J Clin Oncol; 2011 Jun; 41(6):770-5. PubMed ID: 21459893 [TBL] [Abstract][Full Text] [Related]
12. Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma. Ikeda M; Maeda S; Shibata J; Muta R; Ashihara H; Tanaka M; Fujiyama S; Tomita K Oncology; 2004; 66(1):24-31. PubMed ID: 15031595 [TBL] [Abstract][Full Text] [Related]
15. Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma. Kawaoka T; Aikata H; Hyogo H; Morio R; Morio K; Hatooka M; Fukuhara T; Kobayashi T; Naeshiro N; Miyaki D; Hiramatsu A; Imamura M; Kawakami Y; Takahashi S; Waki K; Tsuji K; Kohno H; Kohno H; Moriya T; Chayama K J Dig Dis; 2015 Sep; 16(9):505-12. PubMed ID: 26121102 [TBL] [Abstract][Full Text] [Related]
16. Enhanced therapeutic efficacy of combined use of sorafenib and transcatheter arterial chemoembolization for treatment of advanced hepatocellular carcinoma. Zhou L; Li J; Ai DL; Fu JL; Peng XM; Zhang LZ; Wang JY; Zhao Y; Yang B; Yu Q; Liu CZ; Wang HM Jpn J Clin Oncol; 2014 Aug; 44(8):711-7. PubMed ID: 24855686 [TBL] [Abstract][Full Text] [Related]
17. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma. Nishikawa H; Osaki Y; Kita R; Kimura T; Ohara Y; Takeda H; Sakamoto A; Saito S; Nishijima N; Nasu A; Komekado H; Nishiguchi S Oncol Rep; 2014 Jan; 31(1):65-72. PubMed ID: 24220763 [TBL] [Abstract][Full Text] [Related]
18. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients. Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007 [TBL] [Abstract][Full Text] [Related]
19. Prognosis of advanced hepatocellular carcinoma: a new stratification of Barcelona Clinic Liver Cancer stage C: results from a French multicenter study. Adhoute X; Pénaranda G; Raoul JL; Blanc JF; Edeline J; Conroy G; Perrier H; Pol B; Bayle O; Monnet O; Beaurain P; Muller C; Castellani P; Bronowicki JP; Bourlière M Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):433-40. PubMed ID: 26695429 [TBL] [Abstract][Full Text] [Related]
20. Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma. Lyu N; Kong Y; Mu L; Lin Y; Li J; Liu Y; Zhang Z; Zheng L; Deng H; Li S; Xie Q; Guo R; Shi M; Xu L; Cai X; Wu P; Zhao M J Hepatol; 2018 Jul; 69(1):60-69. PubMed ID: 29471013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]